New hope for liver cancer patients: BSJ019T trial targets tumor control

NCT ID NCT07377487

First seen Jan 31, 2026 · Last updated May 13, 2026 · Updated 14 times

Summary

This study is testing a treatment called BSJ019T in 51 Japanese adults with liver cancer that cannot be removed by surgery and has not responded to or is not eligible for standard treatments. The goal is to see if the treatment can control the cancer in the liver and to check for side effects. Participants will be monitored for at least 6 months to measure tumor response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hyogo College of Medicine Hospital

    NOT_YET_RECRUITING

    Nishinomiya, Hyōgo, 663-8501, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kanazawa University Hospital

    RECRUITING

    Kanazawa, Ishikawa-ken, 920-8641, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kindai University Hospital

    NOT_YET_RECRUITING

    Sayama, Osaka, 589-8511, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center Hospital

    NOT_YET_RECRUITING

    Chuo Ku, Tokyo, 104-0045, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.